Cleerly ISCHEMIA vs CAC Software
AI Verdict
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you require a detailed, non-invasive assessment of coronary artery disease that goes beyond simple calcification scores. This tool is ideal for evaluating the likelihood of vessel-level ischemia, characterizing plaque volume and type, and assessing stenosis severity using CCTA scans to inform personalized treatment strategies. It provides a comprehensive understanding of both anatomical and functional aspects of coronary disease.
View Cleerly ISCHEMIA →Choose CAC Software if…
Choose Imbio's CAC Software if your primary need is an automated and quantitative assessment of coronary artery calcification for cardiovascular risk stratification. This tool is particularly well-suited for analyzing non-contrast chest CT scans to generate an Agatston score, arterial age, and calcified lesion volume, integrating seamlessly into existing workflows for efficient initial risk assessment.
View CAC Software →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | CAC Software |
|---|---|---|
| Pricing | Contact for details | Unknown |
| Deployment | Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) | Cloud-based (SaaS), integrates with PACS |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CAC SoftwareImbio CAC Software emphasizes a fully automated, 'no user input or intervention' process that integrates directly into existing DICOM viewing workflows and PACS, minimizing changes to a radiologist's routine. While Cleerly offers interactive web-based reports and PowerScribe integration, Imbio's approach prioritizes an effortless experience by making results available within the familiar PACS environment without requiring a separate interface to learn.
Clinical Value
Cleerly ISCHEMIACleerly ISCHEMIA offers significantly higher clinical value by non-invasively estimating fractional flow reserve (FFR) and characterizing plaque, directly assessing the likelihood of ischemia at a vessel level. This comprehensive analysis provides more actionable information for personalized diagnosis and treatment planning, including guiding revascularization decisions, and has demonstrated robust diagnostic accuracy and prognostic utility in clinical trials.
Pricing & Value
Cleerly ISCHEMIACleerly ISCHEMIA provides more transparency in its pricing, offering a retail price and mentioning a current discount, which gives potential users some insight into costs. Furthermore, its billability under a Category I CPT code (75580) suggests a clearer pathway for reimbursement, enhancing its value proposition for providers.
Enterprise Readiness
CAC SoftwareImbio CAC Software demonstrates superior enterprise readiness with explicit offerings for Cloud, On-premise, and Partner platform deployment options. Its established partnerships with major healthcare IT vendors like Nuance, Siemens, and GE Healthcare further indicate a highly flexible and scalable solution capable of integrating into diverse enterprise environments.
Innovation
Cleerly ISCHEMIACleerly ISCHEMIA is more innovative as it pushes the diagnostic frontier by providing non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization from CCTA, directly assessing ischemia likelihood. This goes beyond the established practice of coronary artery calcification scoring offered by Tool B, providing a more advanced and comprehensive physiological assessment of heart disease.
Support & Docs
CAC SoftwareImbio CAC Software offers superior support with documented 24/7/365 availability for all customers globally via phone and email, and recommends online case submission. While Cleerly provides support during business hours with after-hours priority, Imbio's round-the-clock accessibility and clear channels for requesting user manuals demonstrate a more robust and accessible support infrastructure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | CAC Software |
|---|---|---|
| Name | Cleerly ISCHEMIA | CAC Software |
| Company | Cleerly | Imbio |
| Primary Analysis Focus | Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level; coronary plaque characterization (volume, type, location) | Automated image post-processing for coronary artery calcification; quantification of calcification within coronary arteries |
| Input Scan Type | CCTA scans | Non-contrast, chest computed tomography (CT) |
| Key Output Metrics | Non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment | Agatston score, arterial age, calcified lesion mass and volume |
| 3D Visualization | 3D digital models of coronary arteries | 3D visualizations and annotated images |
| Integration | Integration with PowerScribe via API | Integrates into existing DICOM viewing workflow |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and CAC Software.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly ISCHEMIA or CAC Software
Backers
Who funded each tool's parent company.